Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
This comparison covers zero-based budgeting and the envelope system, highlighting setup steps and which approach aligns with different spending habits.
17,189 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The iShares SOXX ETF has climbed 93.3% year-to-date through July 6, 2026, as AI infrastructure demand fuels gains acr...
Ethereum has fallen sharply from its peak, leaving investors asking whether this pullback creates a real buying oppor...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
XRP has surged past BNB to claim the fourth-largest spot by market capitalization as Ripple unveils a Brazil expansio...
EU policymakers are weighing new taxes on nicotine pouches. This article explains how price changes influence consume...
NVIDIA CEO Jensen Huang has framed a $40 trillion TAM for labor automation via robotics, prompting a broader look at ...
Artificial intelligence is delivering measurable efficiency in health care, but the race now focuses on who benefits—...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
Roku and Sirius XM sit at opposite ends of the media stock spectrum: one is a fast-growing platform, the other a stea...
The S&P 500 has climbed to new highs, but warning signals are popping up under the surface. This article explains wha...
January brought a standout move in midstream equities as energy transfer's units surged. This in-depth look explains ...